米力农治疗高龄老人慢性心衰疗效及安全性观察.docVIP

米力农治疗高龄老人慢性心衰疗效及安全性观察.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
米力农治疗高龄老人慢性心衰疗效及安全性观察

米力农治疗高龄老人慢性心衰疗效及安全性观察   [摘要] 目的 观察小剂量短期使用米力农治疗高龄老人慢性心力衰竭急性加重期的疗效及安全性。 方法 将140例高龄慢性心力衰竭急性加重期心功能3~4级的住院患者随机分为A、B两组,各70例。A组(对照组)予常规抗心衰治疗,B组(治疗组)在A组常规治疗的基础上,加用小剂量短期米力农治疗(10 mg,泵滴5 h,5d为一疗程)。观察治疗前后患者临床症状、N末端脑钠肽前体水平、血压、心率、左心射血分数等的变化。B组患者治疗前后均行24小时动态心电图检查,采用自动分析以及人工确定分析。 结果 A组总有效率48.5%,B组总有效率82.9%,两组率间差异具有统计学意义(P<0.05);B组患者经小剂量米力农治疗前后,室性心律失常总数无明显的变化(P>0.05)。 结论 小剂量短期使用米力农治疗高龄老人慢性心力衰竭急性加重期安全有效,治疗前后室性心律失常发生总数无明显的变化,值得进一步临床应用及探讨。   [关键词] 米力农;慢性心力衰竭急性加重期;心律失常;高龄   [中图分类号] R541.6+1 [文献标识码] B [文章编号] 1673-9701(2012)02-0060-03      Clinical effect and safely observation on milrinone in treatment of advanced age patients with chronic cardiac failure   CHEN Sui LUO Xuesheng WANG Shanshan LI Qi CHEN Lin HE Lu MENG Yanling   Department of Geriatrics Ward of PLA 113 Hospital, Ningbo 315040, China   [Abstract] Objective To observe the effect and safety on low-does and short-term use of milrinone in treatment of advanced age patients with acute exacerbation of chronic cardiac failure. Methods All of 100 cases of patient with acute exacerbation of chronic cardiac failure in advanced age patients (>80 years) were randomly divided into two groups,A and B. A (control group) received conventional therapy, and B (treatment group)received conventional treatment with the addition of milrinone 10 mg,continuous infusion 5 hours everyday,5 days for treatment. To observe the changes of cardiac function, nerval pro-brain natriuretic peptide level, blood pressure, heart rate, cardiac ultrasonography before and after treatment. Patients of B(treatment group) test with 24 hours hoter before and after treatment and the data were analyzed automatically and manually. Results The total effective rate was 82.9% in treatment group, significantly higher than that in contral group which was 48.5%.There was no obviously change of Arrhythmias before and after treatment in the treatment group. Conclusion It is safe and effective for low-doses and short-term using milrinon in treatment of advanced age pati

文档评论(0)

317960162 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档